Role of oral Minocycline in acute encephalitis syndrome in India - a randomized controlled trial

39Citations
Citations of this article
63Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Acute encephalitis syndrome (AES) is a public health problem in India. Neuroinfections are believed to be the most important etiology. Minocycline is a semisythetic tetracycline having excellent penetration into cerebrospinal fluid, established neuroprotective and antiviral properties besides action on nonviral causes of AES. It has been shown to be effective in animal model of Japanese encephalitis (JE). A randomized, controlled trial of nasogastric/oral minocycline in JE and AES at a single centre in Uttar Pradesh, northern India, was therefore conducted. Methods: Patients beyond 3 years of age - but excluding women aged 16-44 years - hospitalized with AES of

Cite

CITATION STYLE

APA

Kumar, R., Basu, A., Sinha, S., Das, M., Tripathi, P., Jain, A., … Singh, A. S. (2016). Role of oral Minocycline in acute encephalitis syndrome in India - a randomized controlled trial. BMC Infectious Diseases, 16(1). https://doi.org/10.1186/s12879-016-1385-6

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free